Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317848,Alcrsp21,Alcohol response QTL 21,1.899999976158142,0.05,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),19,1044648,46044648,Rat,n/a,region,qtl 1000,61350,Bp32,Blood pressure QTL 32,,0.012,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),19,24818257,62275575,Rat,n/a,region,qtl 1000,1549847,Bss8,Bone structure and strength QTL 8,4,,lumbar vertebra strength trait (VT:0010574),vertebra ultimate force (CMO:0001678),19,1,32379055,Rat,n/a,region,qtl 1000,7411549,Bw130,Body weight QTL 130,5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),19,19177495,62275575,Rat,n/a,region,qtl 1000,8694186,Bw152,Body weight QTL 152,3.34,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),19,3701835,48701835,Rat,n/a,region,qtl 1000,61423,Cia14,Collagen induced arthritis QTL 14,3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),19,11303927,47879277,Rat,n/a,region,qtl 1000,631681,Cm12,Cardiac mass QTL 12,3.33,0.00053,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),19,1,29558305,Rat,n/a,region,qtl 1000,631678,Cm9,Cardiac mass QTL 9,4.27,0.0001,aorta mass (VT:0002845),aorta weight (CMO:0000076),19,1,29558305,Rat,n/a,region,qtl 1000,61328,Eae8,Experimental allergic encephalomyelitis QTL 8,4,,nervous system integrity trait (VT:0010566),percentage of study population developing experimental autoimmune encephalomyelitis during a period of time (CMO:0001047),19,24457627,37140233,Rat,n/a,region,qtl 1000,2298478,Eau8,Experimental allergic uveoretinitis QTL 8,,0.0163,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),19,21407787,62275575,Rat,n/a,region,qtl 1000,9590090,Insglur8,Insulin/glucose ratio QTL 8,10.81,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),19,1,38221845,Rat,n/a,region,qtl 1000,631840,Niddm38,Non-insulin dependent diabetes mellitus QTL 38,3.86,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),19,10739929,26201726,Rat,n/a,region,qtl 1000,8552935,Pigfal10,Plasma insulin-like growth factor 1 level QTL 10,5.7,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),19,1,38221845,Rat,n/a,region,qtl 1000,1558656,Prcs1,Prostate cancer susceptibility QTL 1,5,,prostate integrity trait (VT:0010571),percentage of study population developing ventral prostate tumorous lesions during a period of time (CMO:0000943),19,15939528,38798459,Rat,n/a,region,qtl 1000,1331788,Rf45,Renal function QTL 45,2.818,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal blood flow rate (CMO:0001168),19,17028003,52538299,Rat,n/a,region,qtl 1000,61407,Scl12,Serum cholesterol level QTL 12,,0.001,blood HDL cholesterol amount (VT:0000184),serum high density lipoprotein cholesterol level (CMO:0000361),19,15294524,33991703,Rat,n/a,region,qtl 1000,9590250,Scort11,Serum corticosterone level QTL 11,23.45,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),19,1,38221845,Rat,n/a,region,qtl 1000,9589102,Slep13,Serum leptin concentration QTL 13,4.63,0.001,blood leptin amount (VT:0005667),plasma leptin level (CMO:0000781),19,3701835,48701835,Rat,n/a,region,qtl 1000,10054132,Srcrt9,Stress Responsive Cort QTL 9,2.87,0.0017,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),19,1,27635288,Rat,n/a,region,qtl 1000,1578764,Stresp19,Stress response QTL 19,3.6,0.001,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),19,18993982,62275575,Rat,n/a,region,qtl 1000,61447,Tcas1,Tongue tumor susceptibility QTL 1,6.08,,tongue integrity trait (VT:0010553),squamous cell carcinoma of the tongue maximum tumor diameter (CMO:0001875),19,1957707,46957707,Rat,n/a,region,qtl 1000,724565,Tcas5,Tongue tumor susceptibility QTL 5,10.04,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),19,5007571,43907843,Rat,n/a,region,qtl 1000,1549835,Tcas7,Tongue tumor susceptibility QTL 7,,0.001,tongue integrity trait (VT:0010553),squamous cell carcinoma of the head and neck tumor number (CMO:0001876),19,24455726,43907843,Rat,n/a,region,qtl 1000,724566,Uae12,Urinary albumin excretion QTL 12,5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),19,2432963,62275575,Rat,n/a,region,qtl 1000,724518,Uae19,Urinary albumin excretion QTL 19,5.5,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),19,8072545,47318201,Rat,n/a,region,qtl 1000,1331737,Uae29,Urinary albumin excretion QTL 29,5.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),19,6506761,60220581,Rat,n/a,region,qtl 1000,7247442,Uae39,Urinary albumin excretion QTL 39,,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),19,2432963,47217667,Rat,n/a,region,qtl 1000,9590298,Uminl5,Urine mineral level QTL 5,3.59,0.001,urine mineral amount (VT:0015086),urine electrolyte level (CMO:0000593),19,1,38221845,Rat,n/a,region,qtl